Core Director: Rui-Ming Liu, Ph.D. Idiopathic pulmonary fibrosis (IPF) is a most enigmatic fatal lung disorder. Although significant progress has been made in our understanding of IPF pathogenesis, ...
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a leading developer of liquid biopsy technologies for ...
Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...
Project Leader: A. Brent Carter, M.D. Idiopathic pulmonary fibrosis (IPF) is increasing in prevalence, and the recently approved anti-fibrotic therapies have limited efficacy. Alveolar macrophages ...
Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...
"Lung cancer remains a devastating disease, and Prof. Yarden's approach to tackling drug resistance with bispecific antibodies is precisely the kind of bold, out-of-the-box science that can transform ...
SEOUL, South Korea, Nov. 11, 2025 /PRNewswire/ -- Coreline Soft, a global leader in AI-powered chest diagnostic solutions, today announced its selection as the exclusive artificial intelligence ...
A new initiative aimed at increasing lung cancer screening rates in Iowa is moving forward with support from Eli Lilly and Company, researchers announced.The co ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results